Emerging and Pandemic Infections Consortium

The Emerging and Pandemic Infections Consortium (EPIC) is a collaborative initiative co-established in 2021 by Dr. Scott Gray-Owen to promote and advance a network of infectious disease and pandemic prevention research, with a focus on emerging and pandemic-potential pathogens such as SARS-CoV-1 and -2, tuberculosis, influenza and HIV alongside developing therapeutics, PPE and vaccines. EPIC utilizes the Combined Containment Level 3 (C-CL3) lab located in the Medical Sciences Building, which facilitated research and containment of SARS-CoV-2 during the pandemic and other Biosafety Level 3 pathogens.

EPIC will offer training such as postdoctoral fellowships, industrial internships, career transition awards for senior fellows and research associates and trainee travel/scientific exchange awards.

Interested students/trainees can view participating faculty here and participating UofT divisions here.

Here's a compilation of news stories surrounding EPIC:

Preventing The Next Pandemic (UofT Magazine, April 2022)
UofT Partners With Moderna (UofT News, April 2022)
UofT Groundbreakers Episode 1 (UofT official Youtube Channel, December 2021)
Preventing The Next Pandemic: UofT's EPIC Consortium (UofT News, November 2021)